Pathologic complete response to neoadjuvant therapy in certain breast cancer patients predicts low risk for local metastases
Credit: MD Anderson Cancer Center HOUSTON - Select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy may ...










